Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cara Therapeutics (NASDAQ:
Tag: Cara Therapeutics
Cara Therapeutics Received its Third Buy in a Row
After Needham and Cantor Fitzgerald assigned a Buy rating to Cara Therapeutics in the last month, the company received another
Needham Thinks Cara Therapeutics’ Stock is Going to Recover
Needham analyst Alan Carr reiterated a Buy rating on Cara Therapeutics (NASDAQ: CARA) today and set a price target of
Cantor Fitzgerald Thinks Cara Therapeutics’ Stock is Going to Recover
Cantor Fitzgerald analyst Chiara Russo reiterated a Buy rating on Cara Therapeutics (NASDAQ: CARA) today and set a price target
Analysts Offer Insights on Healthcare Companies: Cara Therapeutics (NASDAQ: CARA), Rigel (NASDAQ: RIGL) and Trevena Inc (NASDAQ: TRVN)
There’s a lot to be optimistic about in the Healthcare sector as 3 experts just weighed in on Cara Therapeutics
Cantor Fitzgerald Thinks Cara Therapeutics’ Stock is Going to Recover
According to The Fly, in a report released yesterday, Chiara Russo from Cantor Fitzgerald reiterated a Buy rating on Cara
Cara Therapeutics Receives a Buy from Cantor Fitzgerald
According to The Fly, cantor Fitzgerald analyst Chiara Russo reiterated a Buy rating on Cara Therapeutics (NASDAQ: CARA) yesterday and